Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Non-Current Assets: 2021-2022

Historic Non-Current Assets for Cardiol Therapeutics (CRDL) over the last 2 years, with Sep 2022 value amounting to $460,618.

  • Cardiol Therapeutics' Non-Current Assets fell 26.73% to $460,618 in Q3 2022 from the same period last year, while for Sep 2022 it was $460,618, marking a year-over-year decrease of 26.73%. This contributed to the annual value of $587,087 for FY2021, which is N/A change from last year.
  • According to the latest figures from Q3 2022, Cardiol Therapeutics' Non-Current Assets is $460,618, which was down 9.08% from $506,630 recorded in Q2 2022.
  • Cardiol Therapeutics' 5-year Non-Current Assets high stood at $17.3 million for Q1 2022, and its period low was $460,618 during Q3 2022.
  • For the 2-year period, Cardiol Therapeutics' Non-Current Assets averaged around $4.5 million, with its median value being $606,164 (2021).
  • Data for Cardiol Therapeutics' Non-Current Assets shows a maximum YoY plummeted of 93.27% (in 2022) over the last 5 years.
  • Cardiol Therapeutics' Non-Current Assets (Quarterly) stood at $583,688 in 2021, then decreased by 26.73% to $460,618 in 2022.
  • Its Non-Current Assets was $460,618 in Q3 2022, compared to $506,630 in Q2 2022 and $17.3 million in Q1 2022.